AS

Active Director Director DIN 06754778
DIN 06754778 First appointment Jan 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2014
Shareholding value •••• Premium profile

About Ayan Saha

Data last updated:

Ayan Saha is a Director at Speranta Biosciences Private Limited (since 2014). The company operates in Healthcare. Speranta Biosciences Private Limited reported revenue of ₹11.9 Lakh (FY 2025).

DIN 06754778
Primary Designation Director
Industry Healthcare
First Appointment 22 Jan 2014
Oldest Company Age 12 yrs
Largest company Speranta Biosciences Private Limited · ₹11.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Speranta Biosciences Private Limited U74999UP2014PTC062167
Director22 Jan 20142014₹11.9 Lakh (FY 2025)Active

Board colleagues of Ayan Saha

NameDINCompanyDesignation
Aveek Saha06754812Speranta Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Speranta Biosciences Private Limited
Premium access

Shareholding and investment profile for Ayan Saha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayan Saha

Ayan Saha currently holds 1 directorship: Speranta Biosciences Private Limited (Director, since 22 Jan 2014, revenue ₹11.9 Lakh (FY 2025)).

Ayan Saha was first appointed on 22 Jan 2014 as Director at Speranta Biosciences Private Limited.

The current boards of Ayan Saha's companies include Aveek Saha (Speranta Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available